Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Weston

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|July 19, 2024
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle ReplicationXin Yin, Yuan Pu, Shuofeng Yuan, et al.
The New England Journal of Medicine|September 3, 2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineCheryl Keech, Gary Albert, Iksung Cho, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Plos Biology|June 12, 2025
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infectionXin Yin, Yuan Pu, Shuofeng Yuan, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2026
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformationHuihui Mou, Bo Gao, Gang Ye, et al.
Molecular Cell|April 30, 2021
Functional landscape of SARS-CoV-2 cellular restrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|July 19, 2024
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle ReplicationXin Yin, Yuan Pu, Shuofeng Yuan, et al.
The New England Journal of Medicine|September 3, 2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle VaccineCheryl Keech, Gary Albert, Iksung Cho, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
Nature Communications|January 15, 2021
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceJing-Hui Tian, Nita Patel, Robert Haupt, et al.
Plos Biology|June 12, 2025
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infectionXin Yin, Yuan Pu, Shuofeng Yuan, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2026
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformationHuihui Mou, Bo Gao, Gang Ye, et al.
Molecular Cell|April 30, 2021
Functional landscape of SARS-CoV-2 cellular restrictionLaura Martin-Sancho, Mary K Lewinski, Lars Pache, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Pageof 4